Egypt

Success stories in managing hemophilia presented at the World Population Conference

 

The Ministry of Health and Population organized a dialogue session entitled “Success Stories in Managing Hemophilia” as part of the activities of the third edition of the World Conference on Population, Health and Human Development (PHDC25), under the patronage of President Abdel Fattah El-Sisi, under the slogan “Empowering Individuals… Promoting Progress… Providing Opportunities”, during the period from November 12 to 15, 2025 in the Administrative Capital.

The session aims to achieve the ministry’s goals in raising the level of care and improving the quality of life of hemophilia patients, through early prevention programs, continuity of care, avoiding financial and medical waste, and integrating patients as productive individuals in society.

Dr. Mehan Abdullah Muhammad, consultant pediatrician and hematologist, reviewed the state’s efforts in building an integrated system of care.

 Egypt was suffering from a large burden with an average of 60 bleeding episodes per year for a patient (weakness). The global average is 23.3 attacks), and decreased quality of life. 

The strategy shifted from treatment on demand to “preventive treatment for all.” By a ministerial decision in April 2023, expanding the service to 19 centers affiliated with the Health Insurance Authority, and launching a “Centre of Excellence” At Egypt Children’s Hospital. The transformation resulted in a reduction in annual bleeding rates by 81.4%, days in hospital by 95%, and the burden on the state budget by 45.4%.

Dr. Islam Annan, CEO of ACCISGHT, highlighted the economic success, with the burden before prophylaxis reaching 2.2 billion pounds annually.

 The new approach has led to savings of more than 800 million pounds annually, with a return on investment of 1.91 (per pound returns 1.91 pounds), with bleeding reduced by 80% and days of stay by 95% for children, preventing 45% of them from reaching working age with a disability.

He concluded by calling for the continuation of preventive treatment for patients into adulthood, warning that stopping it wastes the initial investment and turns them from contributors into dependents.

Related Articles

Back to top button